Codexis to Participate in Upcoming Virtual Healthcare Conferences - Nov 09, 2021

REDWOOD CITY, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management will participate in three upcoming virtual investment conferences.

The 12th Annual Craig-Hallum Alpha Select Conference — November 16, 2021, management will attend and host 1x1 investor meetings

The Stifel 2021 Virtual Healthcare Conference — November 17, 2021 at 2:40 p.m. ET, fireside chat

The Jefferies London Healthcare Conference — November 18, 2021 at 3:00 a.m. ET, on-demand fireside chat

Webcasts of the Stifel and Jefferies presentations will be available in the Investor Relations section of the Company’s website, Replays of the webcasts will be archived for 30 days following their respective presentation dates.

About Codexis
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of pharmaceuticals, food, and industrial products; in the creation of the next generation of life science tools; and as gene therapy and biologic therapeutics. The Company’s unique performance enzymes drive improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics. Codexis enzymes enable the promise of synthetic biology to improve the health of people and the planet. For more information, visit

Investor Relations Contact:
Argot Partners
Stephanie Marks/Carrie McKim
(212) 600-1902

Primary Logo

Back to news